FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553124041> ?p ?o ?g. }

• W2553124041 endingPage "7218" @default.
• W2553124041 startingPage "7207" @default.
• W2553124041 abstract "Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time NamHuk Baek,1,* Ok Won Seo,1,* MinSung Kim,1 John Hulme,2 Seong Soo A An2 1Department of R & D, NanoEntek Inc., Seoul, Republic of Korea; 2Department of BioNano Technology Gachon University, Gyeonggi-do, Republic of Korea *These authors contributed equally to this work Abstract: Recently, increasing numbers of cell culture experiments with 3D spheroids presented better correlating results in vivo than traditional 2D cell culture systems. 3D spheroids could offer a simple and highly reproducible model that would exhibit many characteristics of natural tissue, such as the production of extracellular matrix. In this paper numerous cell lines were screened and selected depending on their ability to form and maintain a spherical shape. The effects of increasing concentrations of doxorubicin (DXR) on the integrity and viability of the selected spheroids were then measured at regular intervals and in real-time. In total 12 cell lines, adenocarcinomic alveolar basal epithelial (A549), muscle (C2C12), prostate (DU145), testis (F9), pituitary epithelial-like (GH3), cervical cancer (HeLa), HeLa contaminant (HEp2), embryo (NIH3T3), embryo (PA317), neuroblastoma (SH-SY5Y), osteosarcoma U2OS, and embryonic kidney cells (293T), were screened. Out of the 12, 8 cell lines, NIH3T3, C2C12, 293T, SH-SY5Y, A549, HeLa, PA317, and U2OS formed regular spheroids and the effects of DXR on these structures were measured at regular intervals. Finally, 5 cell lines, A549, HeLa, SH-SY5Y, U2OS, and 293T, were selected for real-time monitoring and the effects of DXR treatment on their behavior were continuously recorded for 5 days. A potential correlation regarding the effects of DXR on spheroid viability and ATP production was measured on days 1, 3, and 5. Cytotoxicity of DXR seemed to occur after endocytosis, since the cellular activities and ATP productions were still viable after 1 day of the treatment in all spheroids, except SH-SY5Y. Both cellular activity and ATP production were halted 3 and 5 days from the start of the treatment in all spheroids. All cell lines maintained their spheroid shape, except SHSY-5, which behaved in an unpredictable manner when exposed to toxic concentrations of DXR. Cytotoxic effects of DXR towards SH-SY5Y seemed to cause degradation of the extracellular matrix, since all cells were dismantled from the spheroid upon cell death. On the other hand, 293T spheroids revealed retarded cellular activity and ATP productions upon DXR treatment throughout the experiment. Since 293T was the embryonic kidney cells, the fast clearance or neutralizations could have made them resistant towards DXR. In conclusion, the same degree of sensitivity from the 2D system did not translate to a 3D culture system, resulting in higher IC50 values than the 2D system. The varying sensitivities and tolerances to drugs could be better understood with a 3D cell culture system. Keywords: doxorubicin, 3D spheroid, cytotoxicity" @default.
• W2553124041 created "2016-11-30" @default.
• W2553124041 creator A5001004028 @default.
• W2553124041 creator A5013951360 @default.
• W2553124041 creator A5034851147 @default.
• W2553124041 creator A5035314899 @default.
• W2553124041 creator A5057479914 @default.
• W2553124041 date "2016-11-01" @default.
• W2553124041 modified "2023-10-12" @default.
• W2553124041 title "Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time" @default.
• W2553124041 cites W1491781433 @default.
• W2553124041 cites W1533405440 @default.
• W2553124041 cites W1552837917 @default.
• W2553124041 cites W1553426734 @default.
• W2553124041 cites W1798952459 @default.
• W2553124041 cites W1818943734 @default.
• W2553124041 cites W1865162173 @default.
• W2553124041 cites W1909009735 @default.
• W2553124041 cites W1963618034 @default.
• W2553124041 cites W1990903536 @default.
• W2553124041 cites W1992509947 @default.
• W2553124041 cites W1999487669 @default.
• W2553124041 cites W2000744297 @default.
• W2553124041 cites W2005840555 @default.
• W2553124041 cites W2015436916 @default.
• W2553124041 cites W2024520801 @default.
• W2553124041 cites W2027292955 @default.
• W2553124041 cites W2033712039 @default.
• W2553124041 cites W2041636145 @default.
• W2553124041 cites W2045841545 @default.
• W2553124041 cites W2047209914 @default.
• W2553124041 cites W2051580798 @default.
• W2553124041 cites W2056254035 @default.
• W2553124041 cites W2070468167 @default.
• W2553124041 cites W2077760576 @default.
• W2553124041 cites W2081073964 @default.
• W2553124041 cites W2082107683 @default.
• W2553124041 cites W2086034451 @default.
• W2553124041 cites W2091210926 @default.
• W2553124041 cites W2091882385 @default.
• W2553124041 cites W2100409677 @default.
• W2553124041 cites W2111790269 @default.
• W2553124041 cites W2114557817 @default.
• W2553124041 cites W2117076823 @default.
• W2553124041 cites W2120623774 @default.
• W2553124041 cites W2140182328 @default.
• W2553124041 cites W2169640519 @default.
• W2553124041 cites W2279631404 @default.
• W2553124041 cites W2315392383 @default.
• W2553124041 cites W2327728059 @default.
• W2553124041 cites W2328726689 @default.
• W2553124041 cites W943412137 @default.
• W2553124041 cites W2150536786 @default.
• W2553124041 doi "https://doi.org/10.2147/ott.s112566" @default.
• W2553124041 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5125797" @default.
• W2553124041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27920558" @default.
• W2553124041 hasPublicationYear "2016" @default.
• W2553124041 type Work @default.
• W2553124041 sameAs 2553124041 @default.
• W2553124041 citedByCount "87" @default.
• W2553124041 countsByYear W25531240412017 @default.
• W2553124041 countsByYear W25531240412018 @default.
• W2553124041 countsByYear W25531240412019 @default.
• W2553124041 countsByYear W25531240412020 @default.
• W2553124041 countsByYear W25531240412021 @default.
• W2553124041 countsByYear W25531240412022 @default.
• W2553124041 countsByYear W25531240412023 @default.
• W2553124041 crossrefType "journal-article" @default.
• W2553124041 hasAuthorship W2553124041A5001004028 @default.
• W2553124041 hasAuthorship W2553124041A5013951360 @default.
• W2553124041 hasAuthorship W2553124041A5034851147 @default.
• W2553124041 hasAuthorship W2553124041A5035314899 @default.
• W2553124041 hasAuthorship W2553124041A5057479914 @default.
• W2553124041 hasBestOaLocation W25531240411 @default.
• W2553124041 hasConcept C121608353 @default.
• W2553124041 hasConcept C126322002 @default.
• W2553124041 hasConcept C1491633281 @default.
• W2553124041 hasConcept C153911025 @default.
• W2553124041 hasConcept C175369904 @default.
• W2553124041 hasConcept C185592680 @default.
• W2553124041 hasConcept C207200792 @default.
• W2553124041 hasConcept C2776438761 @default.
• W2553124041 hasConcept C2776694085 @default.
• W2553124041 hasConcept C2776715637 @default.
• W2553124041 hasConcept C2777366897 @default.
• W2553124041 hasConcept C2779723316 @default.
• W2553124041 hasConcept C2780192828 @default.
• W2553124041 hasConcept C2781303535 @default.
• W2553124041 hasConcept C3763915 @default.
• W2553124041 hasConcept C502942594 @default.
• W2553124041 hasConcept C54355233 @default.
• W2553124041 hasConcept C55493867 @default.
• W2553124041 hasConcept C60278653 @default.
• W2553124041 hasConcept C71924100 @default.
• W2553124041 hasConcept C81885089 @default.
• W2553124041 hasConcept C86803240 @default.
• W2553124041 hasConcept C95444343 @default.
• W2553124041 hasConceptScore W2553124041C121608353 @default.

• next